Bioloxía do Linfocito
BioLinfo
![Foto de Marina](/img/nophoto.png)
Marina
Blanco Aparicio
Publicacións nas que colabora con Marina Blanco Aparicio (12)
2023
-
A Study of the Prevalence of Asthma in the General Population in Spain
Open Respiratory Archives, Vol. 5, Núm. 2
-
Serum exosome inflamma-miRs are surrogate biomarkers for asthma phenotype and severity
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 78, Núm. 1, pp. 141-155
-
Treatment Patterns of Monoclonal Antibodies in Patients With Severe Uncontrolled Asthma Treated by Pulmonologists in Spain
Open Respiratory Archives, Vol. 5, Núm. 3
-
What's New in the 2022 Consensus for Severe Asthma in Adults
Archivos de Bronconeumologia
2022
-
Consensus document for severe asthma in adults. 2022 update
Open Respiratory Archives, Vol. 4, Núm. 3
-
FENO measurement devices
Open Respiratory Archives, Vol. 4, Núm. 4
-
Monoclonal antibody treatment for severe uncontrolled asthma in Spain: analytical map
Journal of Asthma, Vol. 59, Núm. 10, pp. 1997-2007
2021
-
Biologics in Asthma: Don't Let the Magic Bullets Sink the Boat
Archivos de Bronconeumologia
-
Correction to: REal worlD Effectiveness and Safety of Mepolizumab in a Multicentric Spanish Cohort of Asthma Patients Stratified by Eosinophils: The REDES Study (Drugs, (2021), 81, 15, (1763-1774), 10.1007/s40265-021-01597-9)
Drugs
-
Efficacy of mepolizumab in usual clinical practice and characteristics of responders: Mepolizumab in usual clinical practice
Respiratory Medicine, Vol. 187
-
REal worlD Effectiveness and Safety of Mepolizumab in a Multicentric Spanish Cohort of Asthma Patients Stratified by Eosinophils: The REDES Study
Drugs, Vol. 81, Núm. 15, pp. 1763-1774
2017
-
Concordance of opinions between patients and physicians and their relationship with symptomatic control and future risk in patients with moderate-severe asthma
BMJ Open Respiratory Research, Vol. 4, Núm. 1